M
Mono Pharmacare
MONOPHARMA Share Price
Healthcare11.60
as on 12 Mar 2026 at 15:29
NSE
Market Cap
₹21 Cr
PE Ratio
6.60
ROCE
14.82%
MONOPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
21
PE Ratio
6.60
PB Ratio
0.66
Dividend Yield
-
ROE
9.94%
ROCE
14.82%
Book Value (₹)
17.66
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 56.72% | 56.72% | 56.72% | 56.72% | 56.72% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 37.21% | 36.69% | 35.27% | 35.60% | 34.48% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
MONOPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
SME
BSE Scrip Code
0
NSE Scrip Name
MONOPHARMA
ISIN
INE0OIP01012



